Abstract
Context. Phosphoinositide-3-kinase (PI3K) pathway inhibitors are increasingly used as targeted therapy in malignancies. We discuss here three cases of......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
